AI Verdict
GLRE has stronger fundamentals based on our AI analysis.
GLUE vs GLRE Fundamental Comparison
| Metric | GLUE | GLRE |
|---|---|---|
| Revenue | $123.7M | $729.8M |
| Net Income | $-38.6M | $74.8M |
| Net Margin | -31.2% | 10.3% |
| ROE | -16.6% | 10.6% |
| ROA | -8.6% | 3.4% |
| Current Ratio | 6.12x | N/A |
| Debt/Equity | 0.00x | 0.01x |
| EPS | N/A | $2.17 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
GLUE vs GLRE: Frequently Asked Questions
Is GLUE or GLRE a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), GLRE has stronger fundamentals. GLUE is rated HOLD (69% confidence) while GLRE is rated BUY (72% confidence). This is not investment advice.
How does GLUE compare to GLRE fundamentally?
Monte Rosa Therapeutics, Inc. has ROE of -16.6% vs GREENLIGHT CAPITAL RE, LTD.'s 10.6%. Net margins are -31.2% vs 10.3% respectively.
Which stock pays higher dividends, GLUE or GLRE?
GLUE has a dividend yield of N/A or no dividend while GLRE has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in GLUE or GLRE for long term?
For long-term investing, consider that GLUE has HOLD rating with 69% confidence, while GLRE has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about GLUE vs GLRE?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For GLUE vs GLRE, the AI consensus favors GLRE based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.